This fact sheet provides information about using time temperature indicators to monitor heat exposure of oxytocin, a common drug used to prevent and treat postpartum hemorrhage.

Publication date: May 2014

Region: Global

This report, commissioned by the Washington Global Health Alliance, contains findings from interviews about entering and participating in global health. It includes two case studies of businesses entering global health. The report concludes with recommendations for supporting collaboration and growing the global health sector.

Publication date: September 2011

Region: North America and Europe

This brochure provides an introduction to the Global Health Technologies Coalition, including its membership, activities, and advocacy issues.

Publication date: November 2012

Region: Global

The Global Health Technologies Coalition's website offers information and resources on research and development for new global health tools. It also serves as a clearinghouse of information about coalition activities and global health research and development.

Publication date: 2014

Region: Global

Part of series: Websites

This compilation contains key references and resources to aid program planners in the introduction of oxytocin in the Uniject™ prefilled injection device.

Publication date: September 2009

Region: Global

This report details a study of willingness to pay for oxytocin in the Uniject™ injection system among private midwives in Indonesia. The study also helped to reveal the preferred brands and use of oxytocin, assess the perception of oxytocin in Uniject™ with or without a time-temperature indicator, and identify possible challenges and barriers to market introduction and adoption of oxytocin in Uniject™ in Indonesia.

Publication date: September 2011

Region: Asia

This study was an external analysis of the viability of supporting oxytocin in the Uniject™ injection system as a niche product in both the public and private sectors globally. A major component of this analysis was to conduct separate market analyses of 30 countries identified by the US Agency for International Development as priority countries for maternal health interventions.

Publication date: June 2011

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's work to develop an oxytocin sublingual fast-dissolving tablet presentation that dissolves in less than ten seconds in the patient’s mouth without the need for additional water or diluent. Oxytocin in this type of presentation could potentially increase the reach and efficacy of this lifesaving medication to areas lacking access to skilled health workers, refrigeration, or safe injection equipment.

Publication date: May 2014

Region: Global

Part of series: Technology Updates

This paper was commissioned as an introductory landscape analysis for the aids2031 Science and Technology Working Group as part of a series of working papers under the aids2031 initiative. The paper builds on other recent landscape analysis work in the fields of HIV prevention technologies, therapeutics, and diagnostics and is intended to serve as a resource on the current status of research and development for biomedical and other technological interventions to prevent, treat, and diagnose HIV/AIDS.

Author: Alcorn K

Publication date: October 2008

Region: Global

Part of series: aids2031 working papers

Part of the Technology Updates series, this fact sheet describes PATH’s work to address the problem of vaccines freezing during transport by incorporating a freeze-safe inner vaccine box into vaccine carriers.

Publication date: June 2014

Region: Global

Part of series: Technology Updates

Globally, the leading cause of maternal death is postpartum hemorrhage (PPH). In the absence of a skilled birth attendant, the World Health Organization recommends that a uterotonic drug, preferably oxytocin, be given to prevent PPH. This fact sheet describes how oxytocin in the Uniject™ injection system is one of the tools that programs in Latin America can use to expand access to oxytocin for prevention and treatment of PPH.

Publication date: September 2011

Region: Latin America

Publication date: 2003

Region: Global

Available on CD-ROM, this interactive tool addresses the Indian regulatory systems for product approval in the areas of drugs, vaccines, biopharmaceuticals, medical devices and diagnostics, and biofortified foods. It compares the Indian and US Food and Drugs approval processes; lists key institutions and individuals in India involved in regulatory approvals; lists organizations, committees, and groups that are part of the regulatory system; and provides a database of referenced extracts of key legislations, forms, and templates. This interactive tool allows users to build and analyze various scenarios of product approval applications. Easy-to-navigate and hyperlinked flowcharts provide indicative timelines for approvals, so users can map the various stages in the approval process.

Publication date: November 2007

Region: Asia

Innovation for Global Health is the Global Health Technologies Coalition's e-newsletter focusing on the development and delivery of lifesaving health tools to people in need worldwide. The newsletter provides updates on the latest research and policy developments on innovative tools to prevent, diagnose, and treat diseases. It includes news from US agencies, Congress, the current administration, and the global health community at large.

Publication date: 2014

Region: North America and Europe

Part of series: E-newsletters

This report, the first annual policy report of the Global Health Technologies Coalition, makes recommendations for Congress and the Obama Administration to ensure that the United States maximizes its investment in global health and continues as a leader in global health research and development. The report makes recommendations in three areas: public financing, regulatory pathways, and incentives and innovative financing.

Publication date: 2010

Region: North America and Europe

Part of series: GHTC's annual policy reports

This overview has been developed for program planners considering introduction and/or expansion of the use of oxytocin, and in particular oxytocin packaged in the Uniject™ device, to reduce the incidence of postpartum hemorrhage as a component of their maternal and child health programming. Administering oxytocin is just one component of active management of third stage labor.

Publication date: September 2008

Region: Global

This document provides important details on technical aspects of the Ultra Rice® technology.

Publication date: October 2008

Region: Global

Improving iron status among infants and young children is of continued concern in low- to middle-income countries. This article, published in The Journal of Nutrition, reports on a double-blind, randomized trial among mildly anemic children in Brazil that compared use of rice fortified with micronized ferric pyrophosphate using the Ultra Rice technology with identical nonfortified rice. The study found that, in populations where young children are routinely fed approximately 100 grams of cooked rice daily, fortifying rice with iron may improve iron status at least as well as providing free iron drops.

Author: Beinner M, Velasquez-Meléndez G, Pessoa MC, Greiner T

Publication date: November 2009

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's work on the Information Technology Initiative of the Joint Learning Network for Universal Health Coverage, an innovative learning community where practitioners and policymakers from around the globe co-develop knowledge that focuses on the practical “how to” of achieving universal health coverage.

Publication date: March 2014

Region: Global

Part of series: Technology Updates

This fact sheet from the Global Health Technologies Coalition examines the role of innovation in international development and makes recommendations to elevate global health research in the foreign aid reform process.

Publication date: July 2010

Region: North America and Europe